ADAP
Adaptimmune Therapeutics plc
$0.17
+$0.02(+15.93%)
36
Overall
--
Value
36
Tech
--
Quality
Market Cap
$21.68M
Volume
157.05M
52W Range
$0.04 - $1.01
Target Price
$0.74
EPS Estimates Overview
| Current Quarter | $-0.09 | Next Quarter | $-0.07 |
| Current Year | $-0.48 | Next Year | $-0.21 |
| QoQ Growth | +22.2% | YoY Growth | +56.3% |
| 3Y EPS CAGR | +33.5% | Target Price | $0.74 |
| Consensus | Buy | Upside | +342.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ADAP | $0.17 | +15.9% | 157.05M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Adaptimmune Therapeutics plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW